Marshall Wace North America’s Collegium Pharmaceutical COLL Stock Holding History

Marshall Wace North America’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,614	Closed	-$283K	–	1349
2020 Q3	$283K	Buy	+13,614	New	+$246K	﹤0.01%	1077
2020 Q1	–	Sell	-87,455	Closed	-$1.8M	–	1284
2019 Q4	$1.8M	Sell	87,455 -18,036	-17%	-$301K	0.01%	601
2019 Q3	$1.21M	Sell	105,491 -3,265	-3%	-$37.3K	0.01%	651
2019 Q2	$1.43M	Buy	108,756 +108,742	+776,729%	+$1.45M	0.01%	650
2019 Q1	$0	Buy	+14	New	+$224	﹤0.01%	1606
2018 Q3	–	Sell	-14,447	Closed	-$345K	–	983
2018 Q2	$345K	Buy	+14,447	New	+$355K	﹤0.01%	1155

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Marshall Wace North America's COLL Position: Q4 2020 in Review

Marshall Wace North America sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 13,614 shares — an estimated $283K sold.

Marshall Wace North America first reported a position in COLL in Q2 2018 and held it in 6 quarters. The position peaked at $1.8M in Q4 2019. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

Marshall Wace North America reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 13,614 Collegium Pharmaceutical shares in Q4 2020, an estimated $283K.
Marshall Wace North America first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 6 quarters.
Marshall Wace North America's Collegium Pharmaceutical position peaked at $1.8M in Q4 2019.
138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.